BRIEF-Fate Therapeutics files to say resale of up to 20.9 mln shares of common
January 25, 2017 at 17:07 PM EST
* Fate Therapeutics - files to say resale of up to 20.9 million shares of common stock by the selling stockholders named Source text: (http://bit.ly/2j64uYl) Further company coverage:
